<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03728205</url>
  </required_header>
  <id_info>
    <org_study_id>831417</org_study_id>
    <secondary_id>UPCC-13918</secondary_id>
    <nct_id>NCT03728205</nct_id>
  </id_info>
  <brief_title>Yoga for Solid Tumor</brief_title>
  <official_title>A Pilot Study On The Effect Of Yoga On Fatigue, And Stress Levels In Solid Tumor Cancer Patients Undergoing Active Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abramson Cancer Center of the University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abramson Cancer Center of the University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to ascertain the effect of yoga interventions on
      radiation-related fatigue, and stress in cancer patients with stage I and II solid tumors.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 15, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The feasibility of implementing Eischens yoga interventions for solid tumor cancer patients undergoing radiation therapy. This will be measured by the success rate of recruitment and retention for 10 subjects.</measure>
    <time_frame>12 months</time_frame>
    <description>Feasibility</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effects on fatigue</measure>
    <time_frame>12 months</time_frame>
    <description>Examine the effect of yoga on cancer and radiation related fatigue during radiation therapy. We will use the BFI results both before, during and after radiation therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on Stress Level</measure>
    <time_frame>12 Months</time_frame>
    <description>Examine the effect of yoga on cancer and radiation related fatigue during radiation therapy. We will use the NCCN Distress thermometer results both before, during and after radiation therapy.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Long Term</measure>
    <time_frame>17 months</time_frame>
    <description>Examine the long term effect of yoga to be tested at the 6 months post radiation visit. We will use the BFI and distress thermometer to see if any positive results during yoga are sustained to the 6 month follow up visit.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Solid Tumor, Adult</condition>
  <arm_group>
    <arm_group_label>Observational</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All 10 pilot subjects will be taking yoga</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Yoga</intervention_name>
    <description>Twice weekly yoga sessions for 12 weeks</description>
    <arm_group_label>Observational</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Stage I and II Cancer patients with solid tumors undergoing RT for 4-8 weeks (external
             beam radiation).

          2. Patients of age &gt;18, and all races will be included in the study.

          3. All patients must sign an informed consent form approved for this purpose by the
             Institutional Review Board (IRB) of the University of Pennsylvania.

          4. Patients must be English speaking.

          5. Patients must be able to attend the schedule classes.

             Exclusion Criteria:

          6. Patients with medical restrictions that may interfere with or prevent them from taking
             part in the yoga interventions per their physician orders.

          7. Patients with metastatic disease.

          8. Active smokers. Smoking may interfere with relaxation and breathing modalities of the
             yoga interventions. (Self-reporting smokers that have been smoke free for 6 months may
             be included)

          9. Patients who currently practice or have recently practiced yoga (had not taken a yoga
             class on a regular bases in the last 6 months).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Abramson Cancer Center of the University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Kelly Farrady</investigator_full_name>
    <investigator_title>Clinical Project Manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

